WORK PACKAGE 4
About WP4
Testing and assessments of the remediation technologies
Objectives:
-
to sample, characterize (pollutants, hydrological/geological conditions) and prepare (building infrastructures,
obtain permissions when necessary) the 5 Nymphe sites for pilot testing of the assembled biologic systems; -
to assess at pilot scale, in the field or in confined environment under field conditions, the effectiveness of
reintroduction of assembled bioremediation systems composed of various biologics and their remediation
efficiency, for ensuring the technical feasibility of future scaled-up field application; -
to perform a technical, environmental, and societal assessment of the bioremediation technologies exploiting the assembled biologic systems, using a comprehensive set of methodologies;
-
to benchmark the bioremediation technologies against the standard physicochemical remediation methods regarding effectiveness, cost efficiency, and environmental impacts and risks, to demonstrate their benefits and the importance of their implementation.
Description of work:
WP4 focuses on testing NYMPHE’s bioremediation technologies under real environmental conditions. Systems validated at laboratory scale are deployed across multiple pilot sites in Europe - ranging from aquifers and agricultural soils to wastewater treatment facilities - using both in situ and confined experiments. Activities include site preparation, permitting, installation of test infrastructures, and execution of pilot trials with biologics and technologies developed in WP1–WP3.
In parallel, WP4 conducts comprehensive environmental, economic, and societal assessments. These include LCA, risk analysis, ecotoxicology, ecological impact studies, life-cycle costing, cost-effectiveness analysis, and benchmarking against existing remediation technologies. WP4 also analyses biosafety and regulatory constraints and engages stakeholders through targeted consultations. The outcome is a validated set of bioremediation solutions, supported by evidence of performance, safety, cost-efficiency, and regulatory readiness.